Dr. med. Sebastian Zundler

Professur für Immunzellmigration TT (Else Kröner Clinican Scientist-Professur) Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets (2022) Becker E, Schweda A, Ullrich K, Voskens C, Atreya R, Müller T, Atreya I, et al. Journal article Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis (2022) Voskens C, Stoica D, Rosenberg M, Vitali F, Zundler S, Ganslmayer M, Knott H, et al. Journal article Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease (2022) Schneider I, Allner C, Mühl L, Melde M, Lissner D, Mantzivi E, Glauben R, et al. Journal article Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation (2022) Zundler S, Günther C, Kremer AE, Rothhammer V, Neurath M, Zaiss M Journal article, Review article Neutrophils prevent rectal bleeding in Ulcerative Colitis by peptidyl-arginine deiminase-4-dependent immunothrombosis (2022) Leppkes M, Lindemann A, Goesswein S, Paulus S, Roth D, Hartung A, Liebing E, et al. Conference contribution Neutrophils prevent rectal bleeding in ulcerative colitis by peptidyl-arginine deiminase-4-dependent immunothrombosis (2021) Leppkes M, Lindemann A, Goesswein S, Paulus S, Roth D, Hartung A, Liebing E, et al. Journal article Vedolizumab-associated enthesitis: correlation or causality? (2021) Vitali F, Simon D, Neurath M, Schett G, Zundler S Journal article, Editorial Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial (2021) Voskens C, Stoica D, Roessner S, Vitali F, Zundler S, Rosenberg M, Wiesinger M, et al. Journal article Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study (2021) Mühl L, Becker E, Müller T, Atreya R, Atreya I, Neurath M, Zundler S Journal article α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis (2021) Melde M, Müller T, Schneider IHF, Geppert CI, Mühl L, Besendorf L, Allner C, et al. Journal article